Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy
Conclusion
The growing numbers of therapeutic biomarkers in NSCLC requires judicious triage of limited-volume tissue from small specimens. Our study showed that thoracic small tissue specimens can be used successfully to provide prognostic and predictive information for the current guideline-recommended biomarkers for NSCLC in most cases.
Source: Journal of Clinical Pathology - Category: Pathology Authors: Faber, E., Grosu, H., Sabir, S., San Lucas, F. A., Barkoh, B. A., Bassett, R. L., Luthra, R., Stewart, J., Roy-Chowdhuri, S. Tags: Original research Source Type: research
More News: Cancer | Cancer & Oncology | Cytology | Fine Needle Aspiration | Lung Cancer | Lymphoma | Non-Small Cell Lung Cancer | Pathology | Study | Ultrasound